Commission to publish details of EU product "safety feature" later this year
This article was originally published in Scrip
Executive Summary
Later this year pharmaceutical firms should find out exact details of the safety features they will have to affix to their prescription drugs in order to comply with EU legislation aimed at preventing falsified medicines entering the legitimate supply chain.